Przyborski S A, Christie V B, Hayman M W, Stewart R, Horrocks G M
School of Biological and Biomedical Science, University of Durham, Durham DH1 3LE, UK.
Stem Cells Dev. 2004 Aug;13(4):400-8. doi: 10.1089/scd.2004.13.400.
There are few reliable experimental systems available to study the molecular mechanisms that govern human embryonic development. Embryonal carcinoma (EC) cells are pluripotent stem cells derived from teratocarcinomas and are considered the malignant counterparts of human embryonic stem (ES) cells. Several of the existing human EC stem cell lines provide robust and simple culture systems to study certain aspects of cellular differentiation in a manner pertinent to human embryogenesis. Here we review the strategies used to derive and characterize the established and recognized human EC stem cell line TERA2.cl.SP12. Furthermore, we demonstrate the value of human EC stem cells as a model of early development and focus on cell fate determination in the embryonic ectoderm.
几乎没有可靠的实验系统可用于研究控制人类胚胎发育的分子机制。胚胎癌细胞(EC)是源自畸胎癌的多能干细胞,被认为是人类胚胎干细胞(ES)的恶性对应物。现有的几种人类EC干细胞系提供了强大而简单的培养系统,以与人类胚胎发生相关的方式研究细胞分化的某些方面。在这里,我们回顾了用于衍生和表征已建立并得到认可的人类EC干细胞系TERA2.cl.SP12的策略。此外,我们展示了人类EC干细胞作为早期发育模型的价值,并着重于胚胎外胚层中的细胞命运决定。